Matthias Stelljes

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 719 citations

Life Sciences, Hematology, Immunology +14

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Gèrard Socié, Claudia Schmoor, Wolfgang Bethge et al. · Blood · 2011 · 303 citations · Full text

Life Sciences, Immunology, Clinical Immunology +15

Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial

Jürgen Finke, Claudia Schmoor, Wolfgang Bethge et al. · The Lancet Haematology · 2017 · 112 citations

Life Sciences, Hematology, Immunology +17

Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial

Jürgen Finke, Claudia Schmoor, Wolfgang Bethge et al. · Biology of Blood and Marrow Transplantation · 2012 · 61 citations · Full text

Medicine, Hematology, Immunology +17

Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition

A. Ossami Saidy, Christophe Peczynski, Catherine Thiéblemont et al. · HemaSphere · 2025 · 11 citations · Full text

Medicine, Hematology, Oncology +17